• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis.

作者信息

Thompson Alan

机构信息

Department of Clinical Neurology, Institute of Neurology, Queen Square, London WC1N 3BG, UK.

出版信息

Mult Scler. 2004 Jun;10 Suppl 1:S2-7. doi: 10.1191/1352458504ms1024oa.

DOI:10.1191/1352458504ms1024oa
PMID:15218803
Abstract

Patients with the primary progressive form of multiple sclerosis (PPMS) have a unique clinical course and demonstrate additional demographic and imaging features, which separate them from the relapsing/remitting form of the condition. Whether these features indicate a fundamental difference in the underlying pathogenesis of the condition or simply reflect opposite ends of a clinical spectrum is unclear. What is clear, however, is that this form of MS provides a valuable model of progression, which has the potential to explain this most disabling component of the disease process. The lack of the hallmark relapses and remissions in PPMS poses diagnostic difficulties, some of which have been addressed by recently published diagnostic criteria. Following diagnosis, the need for information, specific to this form of MS, must be recognized and addressed.

摘要

相似文献

1
Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis.
Mult Scler. 2004 Jun;10 Suppl 1:S2-7. doi: 10.1191/1352458504ms1024oa.
2
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?原发性进行性多发性硬化症:多发性硬化疾病谱的一部分还是独立的疾病实体?
Acta Neuropathol. 2012 May;123(5):627-38. doi: 10.1007/s00401-012-0953-0. Epub 2012 Feb 11.
3
Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.原发性进行性多发性硬化症的诊断标准:再评价。
Mult Scler. 2009 Dec;15(12):1459-65. doi: 10.1177/1352458509348422. Epub 2009 Dec 7.
4
The diagnosis of primary progressive multiple sclerosis.
J Neurol Sci. 2003 Feb 15;206(2):145-52. doi: 10.1016/s0022-510x(02)00346-5.
5
Natural history of primary progressive multiple sclerosis.原发性进行性多发性硬化症的自然病史。
Mult Scler. 2004 Jun;10 Suppl 1:S8-13; discussion S13-5. doi: 10.1191/1352458504ms1025oa.
6
Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.原发性进行性多发性硬化症由放射孤立综合征演变而来。
Ann Neurol. 2016 Feb;79(2):288-94. doi: 10.1002/ana.24564. Epub 2015 Dec 29.
7
Diagnostic criteria for primary progressive multiple sclerosis: a position paper.原发性进行性多发性硬化症的诊断标准:立场文件。
Ann Neurol. 2000 Jun;47(6):831-5.
8
Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.原发性进行性和复发缓解型多发性硬化症之间的遗传差异:免疫相关基因变异性的影响。
Mult Scler Relat Disord. 2019 Apr;29:130-136. doi: 10.1016/j.msard.2019.01.033. Epub 2019 Jan 24.
9
A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry.当代 NARCOMS 注册研究中原发性进行性多发性硬化参与者的特征分析。
Mult Scler. 2018 Jun;24(7):951-962. doi: 10.1177/1352458517711274. Epub 2017 May 19.
10
Real-world challenges in the diagnosis of primary progressive multiple sclerosis.原发性进行性多发性硬化症诊断中的现实挑战。
Eur J Neurol. 2023 Dec;30(12):3799-3808. doi: 10.1111/ene.16042. Epub 2023 Sep 15.

引用本文的文献

1
Primary Progressive Multiple Sclerosis: New Therapeutic Approaches.原发性进行性多发性硬化症:新的治疗方法
Neuropsychopharmacol Rep. 2025 Sep;45(3):e70039. doi: 10.1002/npr2.70039.
2
Myelin-reactive B cells exacerbate CD4 T cell-driven CNS autoimmunity in an IL-23-dependent manner.髓鞘反应性 B 细胞以依赖 IL-23 的方式加剧 CD4 T 细胞驱动的中枢神经系统自身免疫。
Nat Commun. 2024 Jun 26;15(1):5404. doi: 10.1038/s41467-024-49259-0.
3
Neural Processes of Psychological Stress and Relaxation Predict the Future Evolution of Quality of Life in Multiple Sclerosis.
心理应激与放松的神经过程可预测多发性硬化症患者生活质量的未来演变。
Front Neurol. 2021 Nov 23;12:753107. doi: 10.3389/fneur.2021.753107. eCollection 2021.
4
Progressive Onset Multiple Sclerosis: Demographic, Clinical and Laboratory Characteristics of Patients With and Without Relapses in the Course.进行性起病的多发性硬化症:病程中有无复发患者的人口统计学、临床和实验室特征
Noro Psikiyatr Ars. 2019 Mar;56(1):23-26. doi: 10.5152/npa.2017.19269. Epub 2018 Jul 4.
5
The MRI central vein marker; differentiating PPMS from RRMS and ischemic SVD.
Neurol Neuroimmunol Neuroinflamm. 2018 Sep 26;5(6):e496. doi: 10.1212/NXI.0000000000000496. eCollection 2018 Nov.
6
Sex chromosome contributions to sex differences in multiple sclerosis susceptibility and progression.性染色体对多发性硬化症易感性和进展的性别差异的贡献。
Mult Scler. 2018 Jan;24(1):22-31. doi: 10.1177/1352458517737394.
7
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): study protocol for a randomized controlled trial.机器人辅助步态训练与传统疗法对重度残疾进展性多发性硬化症患者活动能力的疗效比较(RAGTIME):一项随机对照试验的研究方案
Trials. 2017 Feb 27;18(1):88. doi: 10.1186/s13063-017-1838-2.
8
The importance of studying sex differences in disease: The example of multiple sclerosis.研究疾病中性别差异的重要性:以多发性硬化症为例。
J Neurosci Res. 2017 Jan 2;95(1-2):633-643. doi: 10.1002/jnr.23955.
9
Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study.进展性多发性硬化症与肌萎缩侧索硬化症中的灰质损伤:基于体素的形态测量MRI研究
Neurol Sci. 2015 Mar;36(3):371-7. doi: 10.1007/s10072-014-1954-7. Epub 2014 Sep 17.
10
Meeting the needs of people with primary progressive multiple sclerosis, their families, and the health-care community.满足原发性进行性多发性硬化症患者及其家人以及医疗保健界的需求。
Int J MS Care. 2011 Summer;13(2):65-74. doi: 10.7224/1537-2073-13.2.65.